1468 related articles for article (PubMed ID: 30822098)
21. Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation.
Petite SE; Murphy JA
Ann Pharmacother; 2019 Feb; 53(2):144-150. PubMed ID: 30175589
[TBL] [Abstract][Full Text] [Related]
22. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
23. Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study.
Anbesse ZK; Mega TA; Tesfaye BT; Negera GZ
PLoS One; 2020; 15(10):e0239665. PubMed ID: 33022006
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.
Kumbhare S; Pleasants R; Ohar JA; Strange C
Ann Am Thorac Soc; 2016 Jun; 13(6):803-10. PubMed ID: 26974689
[TBL] [Abstract][Full Text] [Related]
25. Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Bollu V; Ernst FR; Karafilidis J; Rajagopalan K; Robinson SB; Braman SS
Int J Chron Obstruct Pulmon Dis; 2013; 8():631-9. PubMed ID: 24353413
[TBL] [Abstract][Full Text] [Related]
26. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
27. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.
Wheaton AG; Pleasants RA; Croft JB; Ohar JA; Heidari K; Mannino DM; Liu Y; Strange C
J Asthma; 2016 Sep; 53(7):720-31. PubMed ID: 27043854
[TBL] [Abstract][Full Text] [Related]
28. Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database.
Jacobs DM; Noyes K; Zhao J; Gibson W; Murphy TF; Sethi S; Ochs-Balcom HM
Ann Am Thorac Soc; 2018 Jul; 15(7):837-845. PubMed ID: 29611719
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease.
Amin AN; Bollu V; Stensland MD; Netzer L; Ganapathy V
Am J Health Syst Pharm; 2018 Mar; 75(6):359-366. PubMed ID: 29523532
[TBL] [Abstract][Full Text] [Related]
30. Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.
Cui Y; Zhan Z; Ma Y; Huang K; Liang C; Mao X; Zhang Y; Ren X; Lei J; Chen Y; Yang T; Wang C
Respir Res; 2022 Feb; 23(1):28. PubMed ID: 35151338
[TBL] [Abstract][Full Text] [Related]
31. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality.
Abrams TE; Vaughan-Sarrazin M; Van der Weg MW
Psychosomatics; 2011; 52(5):441-9. PubMed ID: 21907063
[TBL] [Abstract][Full Text] [Related]
32. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.
Bartels W; Adamson S; Leung L; Sin DD; van Eeden SF
Int J Chron Obstruct Pulmon Dis; 2018; 13():1647-1654. PubMed ID: 29872284
[TBL] [Abstract][Full Text] [Related]
33. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender.
Sánchez-Muñoz G; Lopez-de-Andrés A; Hernández-Barrera V; Jiménez-García R; Pedraza-Serrano F; Puente-Maestu L; de Miguel-Díez J
PLoS One; 2019; 14(1):e0211222. PubMed ID: 30682190
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
[TBL] [Abstract][Full Text] [Related]
35. Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization.
Goto T; Faridi MK; Gibo K; Camargo CA; Hasegawa K
Respir Med; 2017 Oct; 131():6-10. PubMed ID: 28947044
[TBL] [Abstract][Full Text] [Related]
36. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
Melzer AC; Feemster LC; Collins MP; Au DH
J Hosp Med; 2016 Apr; 11(4):257-63. PubMed ID: 26663891
[TBL] [Abstract][Full Text] [Related]
37. Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease.
Åberg J; Hasselgren M; Montgomery S; Lisspers K; Ställberg B; Janson C; Sundh J
Int J Chron Obstruct Pulmon Dis; 2019; 14():961-969. PubMed ID: 31123398
[No Abstract] [Full Text] [Related]
38. Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.
Jiang X; Xiao H; Segal R; Mobley WC; Park H
Clin Ther; 2018 Apr; 40(4):613-626.e1. PubMed ID: 29609879
[TBL] [Abstract][Full Text] [Related]
39. Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.
Melzer AC; Feemster LC; Collins MP; Au DH
J Gen Intern Med; 2016 Jun; 31(6):623-9. PubMed ID: 26902236
[TBL] [Abstract][Full Text] [Related]
40. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease.
Matkovic Z; Huerta A; Soler N; Domingo R; Gabarrús A; Torres A; Miravitlles M
Respiration; 2012; 84(1):17-26. PubMed ID: 22327370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
